|
Fairview
Press, 2450 Riverside Ave. Minneapolis, MN 55454, www.fairviewpress.org ;
August 2002. (Book, References)
Surviving
"Terminal" Cancer: Clinical Trials, Drug Cocktails, and Other
Treatments Your Doctor Won't Tell You About
Ben Williams,
PhD
| REFERENCES |
|
|
|
| Chapter 1 - Diagnosis: Glioblastoma multiforme "The
Terminator" |
[1]
Eric C. Holland
Glioblastoma
multiforme: The terminator
Proc.
Natl. Acad. Sci. USA, Vol. 97,
Issue 12, 6242-6244, June 6, 2000 (Commentary, Full Text)
|
|
[2]
N.A.
|
|
|
| Chapter 2 - Searching for Treatment |
[1]
Wilson
CB
Glioblastoma: the past, the present, and the
future
Clin Neurosurg 1992;38:32-48 (Review
Article, Reference)
|
|
[2]
Hatanaka
H, Nakagawa Y.
Clinical
results of long-surviving brain tumor patients who underwent boron neutron
capture therapy
Int J
Radiat Oncol Biol Phys 1994 Mar 30;28(5):1061-6 (Clinical Study, Abstract)
|
|
[3]
Coderre
JA, Elowitz EH, Chadha M, Bergland R, Capala J, Joel DD, Liu HB, Slatkin DN,
Chanana AD.
Boron
neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine
and epithermal neutrons: trial design and early clinical results
J Neurooncol 1997 May;33(1-2):141-52
(Clinical Study, Abstract)
|
|
[4]
N.A.
|
|
[5]
Glantz
MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L,
Lekos A, Louis S
A
randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis
in adults with newly diagnosed brain tumors
Neurology
1996 Apr;46(4):985-91 (Clinical Study, Abstract)
|
|
[6]
Salazar AM, Levy HB, Ondra S, Kende M, Scherokman B, Brown D, Mena H, Martin
N, Schwab K, Donovan D, Dougherty D, Pulliam M, Ippolito M, Graves M, Brown H,
Ommaya A.
Long-term treatment of malignant gliomas with intramuscularly
administered polyinosinic-polycytidylic acid stabilized with polylysine and
carboxymethylcellulose: an open pilot study
Neurosurgery 1996 Jun;38(6):1096-103 (Clinical Study, Abstract)
|
|
[7]
Couldwell
WT, Weiss MH, DeGiorgio CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS,
Apuzzo ML.
Clinical and
radiographic response in a minority of patients with recurrent malignant gliomas
treated with high-dose tamoxifen
Neurosurgery 1993 Mar;32(3):485-9 (Clinical Study, Abstract)
|
|
[8] Zhang
W, Yamada H, Sakai N, Niikawa S, Nozawa Y.
Enhancement
of radiosensitivity by tamoxifen in C6 glioma cells
Neurosurgery 1992
Oct;31(4):725-9 (Cell Culture Study |
|
[9]
Mastronardi
L, Puzzilli F, Couldwell WT, Farah JO, Lunardi P.
Tamoxifen
and carboplatin combinational treatment of high-grade gliomas. Results of a
clinical trial on newly diagnosed patients
J
Neurooncol 1998 May;38(1):59-68 (Clinical Study, Abstract)
|
|
[10]
Barker
FG 2nd, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK,
McDermott MW, Sneed PK, Wara WM, Wilson CB.
Radiation
response and survival time in patients with glioblastoma multiforme
J Neurosurg 1996
Mar;84(3):442-8
(Clinical Study, Abstract)
|
|
[11]
Fernandez
PM, Zamorano L, Yakar D, Gaspar L, Warmelink C.
Permanent
iodine-125 implants in the up-front treatment of malignant gliomas
Neurosurgery
1995 Mar;36(3):467-73 (Clinical Study, Abstract)
|
|
[12]
Halligan
JB, Stelzer KJ, Rostomily RC, Spence AM, Griffin TW, Berger MS.
Operation
and permanent low activity 125I brachytheraphy for recurrent high-grade
astrocytomas
Int J
Radiat Oncol Biol Phys 1996 Jun 1;35(3):541-7 (Clinical Study, Abstract)
|
|
|
| Chapter 3 - Improving My Odds for Survival |
[1]
Levin
VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson
CB
Radiation
therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine,
and vincristine for the treatment of anaplastic gliomas
Int J Radiat Oncol Biol Phys 1995 Apr 30;32(1):75-83 (Clinical Study,
Abstract)
|
|
[2] Figueredo A, Arnold A, Goodyear M, Findlay B, Neville A,
Normandeau R, Jones A
Addition
of verapamil and tamoxifen to the initial chemotherapy of small cell lung
cancer. A phase I/II study
Cancer
1990 May 1;65(9):1895-902 (Clinical Study, Abstract)
|
|
[3]
Bowles
AP Jr, Pantazis CG, Wansley W
Use of
verapamil to enhance the antiproliferative activity of BCNU in human glioma
cells: an in vitro and in vivo study
J
Neurosurg 1990 Aug;73(2):248-53 (Cell Culture Study | Animal Study,
Abstract)
|
|
[4]
Aas AT,
Brun A, Pero RW, Salford LG.
Chlorpromazine
in combination with nitrosourea inhibits experimental glioma growth
Br J Neurosurg
1994;8(2):187-92 (Cell Culture Study, Abstract)
|
|
[5], [6] N.A.
|
|
[7]
Murovic
J, Turowski K, Wilson CB, Hoshino T, Levin V
Computerized
tomography in the prognosis of malignant cerebral gliomas
J
Neurosurg 1986 Dec;65(6):799-806 (Clinical Study, Abstract)
|
|
[8]
Lissoni P, Meregalli S, Nosetto
L, Barni S, Tancini G, Fossati V, Maestroni G.
Increased survival time
in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus
melatonin compared to radiotherapy alone
Oncology
1996 Jan-Feb;53(1):43-6 (Clinical Study, Abstract)
|
|
[9]
Das
UN, Prasad VV, Reddy DR
Local
application of gamma-linolenic acid in the treatment of human gliomas
Cancer
Lett 1995 Aug 1;94(2):147-55 (Clinical Study, Abstract)
|
|
|
| Chapter 4 - Salvaging
a Life |
N.A.
|
|
|
| Chapter 5 -
Toward a Rational Treatment Strategy |
[1]
Rowlands
MG, Budworth J, Jarman M, Hardcastle IR, McCague R, Gescher A
Comparison between inhibition of protein kinase C
and antagonism of calmodulin by tamoxifen analogues
Biochem Pharmacol 1995 Aug 25;50(5):723-6 (Cell Culture Study, Abstract)
|
|
[2],
[3], [4], [5] N.A.
|
|
[6]
HA
Fine, JS Loeffler, A Kyritsis, P Wen, PM Black, VA Levin, S Graham, WKA Yung
A phase II trial of the
anti-angiogenic agent,
thalidomide, in patients with recurrent high-grade gliomas
ASCO
Proceedings, 1997 Annual Meeting, Abstract No. 1372 (Clinical Study)
|
|
[7]
Jo
Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of Carboplatin and Thalidomide in
Recurrent Glioblastoma Multiforme
ASCO
Proceedings, 1999 Annual Meeting, Abstract No.
551 (Clinical Study)
|
|
|
| Chapter 6 -
Shared Experiences |
[1],
[2] N.A.
|
|
[3]
Plowman
J, Waud
WR, Koutsoukos AD, Rubinstein LV, Moore TD, Grever MR
Preclinical
antitumor activity of temozolomide in mice: efficacy against human brain tumor
xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea
Cancer
Res 1994 Jul 15;54(14):3793-9 (Animal Study, Abstract)
|
|
[4]
Newlands
ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH,
Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG.
The Charing Cross Hospital experience with
temozolomide in patients with gliomas
Eur J Cancer 1996 Dec;32A(13):2236-41 (Clinical
Study, Abstract)
|
|
|
| Chapter 7 - Conventions of
the Medical System and Their Ramifications |
[1], [2],
[3], [4] N.A. |
|
[5]
Yung WK,
Kyritsis AP, Gleason MJ, Levin VA
Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid
Clin Cancer Res 1996 Dec;2(12):1931-5 (Clinical Study,
Abstract)
|
|
[6] N.A.
|
|
|
| Chapter 8 -
Arbitrary Policies Exclude Promising Treatment |
[1]
Laperriere
NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, Pintilie M, Bernstein
M
Randomized
study of brachytherapy in the initial management of patients with malignant
astrocytoma
Int
J Radiat Oncol Biol Phys 1998 Jul 15;41(5):1005-11 (Clinical
Study, Abstract)
|
|
[2]
Brem
H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M,
Brem S, Mohr G, et al.
Placebo-controlled trial of safety and efficacy of
intraoperative controlled delivery by biodegradable polymers of chemotherapy for
recurrent gliomas. The Polymer-brain Tumor Treatment Group
Lancet 1995 Apr 22;345(8956):1008-12 (Clinical Study,
Abstract)
|
|
[3] N.A.
|
|
[4]
R
Albright, M Brada, J Brunner, MH Dugan, K Fink, R Fredericks, VA Levin, J
Olson,
M Prados, A Spence, N Yue, A Yung, S Zaknoen
Randomized Trial of Temodal
(TEM) Vs. Procarbazine (PCB) in Glioblastoma
Multiforme (GBM) at First Relapse
ASCO Proceedings, 1999 Annual Meeting, Abstract
(Clinical
Study)
|
|
[5] Yung
WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS,
Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N,
Dugan M, Zaknoen S, Levin VA.
Multicenter phase II trial of temozolomide in
patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at
first relapse. Temodal Brain Tumor Group
J
Clin Oncol 1999 Sep;17(9):2762-71 (Clinical
Study, Abstract)
|
|
[6a]
M
Brada,
DG Thomas, NM Bleehen, JT Roberts, F Senanayake, P Abram, PL Lantos, TH Moss, JW
Ironside, JB Whaley, SP Stenning
Medical Research Council
(MRC) Randomised Trial of
Adjuvant Chemotherapy in High Grade Glioma (HGG)
ASCO
Proceedings, 1998 Annual Meeting,
Abstract No. 1543 (Clinical
Study)
|
|
[6b]
Fine
HA, Dear KB, Loeffler JS, Black PM, Canellos GP
Meta-analysis of
radiation therapy with and without adjuvant chemotherapy for malignant gliomas
in adults
Cancer 1993 Apr 15;71(8):2585-97 (Evaluation Study, Abstract)
|
|
[7]
Couldwell
WT, Weiss MH, DeGiorgio CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS,
Apuzzo ML.
Clinical and
radiographic response in a minority of patients with recurrent malignant gliomas
treated with high-dose tamoxifen
Neurosurgery 1993 Mar;32(3):485-9 (Clinical Study,
Abstract)
|
|
[8]
Vertosick,
F.T., and Selker, R.G.
The treatment of newly diagnosed glioblastoma
multiforme using high dose tamoxifen (TMX), radiotherapy and convenzional
chemotherapy
AACR
Proceedings, 1997 Annual Meeting, Abstract No. 2887 (Clinical Study)
|
|
[9]
Yung WK,
Kyritsis AP, Gleason MJ, Levin VA
Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid
Clin Cancer Res 1996 Dec;2(12):1931-5 (Clinical Study,
Abstract)
|
|
[10]
N.A.
|
|
[11]
Jo
Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of Carboplatin and Thalidomide in
Recurrent Glioblastoma Multiforme
ASCO
Proceedings, 1999 Annual Meeting, Abstract No.
551 (Clinical Study)
|
|
[12]
N.A.
|
|
|
| Chapter 9 -
Ethical Implications of the Clinical Trial System |
[1], [2],
[3], [4], [5] N.A. |
|
[6]
Grant
SC, Kris MG, Houghton AN, Chapman PB
Long
survival of patients with small cell lung cancer after adjuvant treatment with
the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guerin
Clin Cancer Res 1999 Jun;5(6):1319-23 (Clinical
Study, Abstract)
|
|
|
| Chapter 10 -
Phase-III Trials: Gold Standard or Fool's Gold? |
[1], [2],
[3], [4] N.A. |
|
[5]
Videtic
GM, Gaspar LE, Zamorano L, Fontanesi J, Levin KJ, Kupsky WJ, Tekyi-Mensah S.
Use of
the RTOG recursive partitioning analysis to validate the benefit of iodine-125
implants in the primary treatment of malignant gliomas.
Int J
Radiat Oncol Biol Phys 1999 Oct 1;45(3):687-92 (Clinical
Study, Abstract)
|
|
[6] N.A.
|
|
[7]
Esteller
M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V,
Baylin SB, Herman JG
Inactivation of the DNA-repair gene MGMT and
the clinical response of gliomas to alkylating agents
N Engl J Med 2000 Nov
9;343(19):1350-4 (Clinical Study, Abstract)
|
|
[8] N.A.
|
|
|
| Chapter 11 - Bastille Day
for Cancer Patient |
N.A.
|
|
|
| Chapter 12 - Alternative
Medicine |
[1], [2],
[3], [4], [5], [6] N.A.
|
|
[7]
Chlebowski
RT, Lillington L, Nystrom JS, Sayre J
Late
mortality and levamisole adjuvant therapy in colorectal cancer
Br J
Cancer 1994 Jun;69(6):1094-7 (Clinical Study, Abstract)
|
|
[8], [9],
[10] N.A.
|
|
[11] Filov VA, Gershanovich ML, Danova LA, Ivin BA
Experience
of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer
patients
Invest New
Drugs 1995;13(1):89-97 (Clinical Study, Abstract)
|
|
[12] N.A.
|
|
[13]
Chlebowski
RT, Bulcavage L, Grosvenor M, Oktay E, Block JB, Chlebowski JS,
Ali I, Elashoff R
Hydrazine
sulfate influence on nutritional status and survival in non-small-cell lung
cancer
J
Clin Oncol 1990 Jan;8(1):9-15 (Clinical Study, Abstract)
|
|
[14]
Loprinzi
CL, Kuross SA, O'Fallon JR, Gesme DH Jr, Gerstner JB, Rospond RM, Cobau CD,
Goldberg RM.
Randomized
placebo-controlled evaluation of hydrazine sulfate in patients with advanced
colorectal cancer
J
Clin Oncol 1994 Jun;12(6):1121-5 (Clinical Study, Abstract)
|
|
[15]
Kosty
MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris
JC, Mortimer J, Green MR
Cisplatin,
vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a
randomized placebo-controlled, double-blind phase III study of the Cancer and
Leukemia Group B
J Clin Oncol 1994 Jun;12(6):1113-20 (Clinical Study, Abstract)
|
|
[16]
Loprinzi
CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW,
Jett JR, Ghosh C, Pfeifle DM, et al
Placebo-controlled
trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung
cancer
J
Clin Oncol 1994 Jun;12(6):1126-9 (Clinical Study, Abstract)
|
|
[17]
Kaegi
E
Unconventional
therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the
Canadian Breast Cancer Research Initiative
CMAJ
1998 May 5;158(9):1157-9 (Review Article, Reference | Full Text)
|
|
[18] N.A.
|
|
[19]
Kuttan G, Menon
LG, Antony S, Kuttan
R
Anticarcinogenic
and antimetastatic activity of Iscador
Anticancer
Drugs 1997 Apr;8 Suppl 1:S15-6 (Animal Study, Abstract)
|
|
[20]
Antony
S, Kuttan R, Kuttan G
Effect
of viscum album in the inhibition of lung metastasis in mice induced by B16F10
melanoma cells
J Exp
Clin Cancer Res 1997 Jun;16(2):159-62 (Animal Study, Abstract)
|
|
[21]
Kuttan G, Kuttan R
Reduction
of leukopenia in mice by "viscum album" administration during
radiation and chemotherapy
Tumori 1993 Feb
28;79(1):74-6 (Animal Study, Abstract)
|
|
[22]
Lenartz
D, Stoffel B, Menzel J, Beuth J.
Immunoprotective
activity of the galactoside-specific lectin from mistletoe after tumor
destructive therapy in glioma patients
Anticancer
Res 1996 Nov-Dec;16(6B):3799-802 (Clinical Study, Abstract)
|
|
[23]
Lenartz
D, Dott U, Menzel J, Schierholz JM, Beuth J
Survival
of glioma patients after complementary treatment with galactoside-specific
lectin from mistletoe
Anticancer
Res 2000 May-Jun;20(3B):2073-6 (Clinical Study, Abstract)
|
|
[24]
Jagiello-Wojtowicz
E, Kleinrok Z, Urbanska EM
Ukrain
(NSC-631570) in experimental and clinical studies: a review
Drugs Exp Clin Res 1998;24(5-6):213-9 (Review
Article, Abstract)
|
|
[25] Not
Found
|
|
[26]
Susak
YM, Zemskov VS, Yaremchuk OY, Kravchenco OB, Yatsyk IM, Korsh OB
Comparison
of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer
Drugs Exp Clin Res 1996;22(3-5):115-22 (Clinical
Study, Abstract)
|
|
[27]
Zemskov
VS, Procopchuk OL, Susak YM, Zemskov SV, Hodysh YY, Zemskova MV
Ukrain
(NSC-631570) in the treatment of pancreas cancer
Drugs Exp Clin Res 2000;26(5-6):179-90 (Clinical
Study, Abstract)
|
|
[28] Jaeckle
KA, Mittelman A, Hill FH
Phase
II trial of Serratia marcescens extract in recurrent malignant astrocytoma
J
Clin Oncol 1990 Aug;8(8):1408-18 (Clinical Study, Abstract)
|
|
[29] Csatary
LK, Eckhardt S, Bukosza I, Czegledi F, Fenyvesi C, Gergely P, Bodey B,
Csatary CM
Attenuated
veterinary virus vaccine for the treatment of cancer
Cancer
Detect Prev 1993;17(6):619-27 (Clinical Study, Abstract)
|
|
[30] Batliwalla
FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC,
Gregersen PK, Armstrong CA
A
15-year follow-up of AJCC stage III malignant melanoma patients treated
postsurgically with Newcastle disease virus (NDV) oncolysate and determination
of alterations in the CD8 T cell repertoire
Mol
Med 1998 Dec;4(12):783-94 (Clinical Study, Abstract)
|
|
[31] de
la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M,
Burchardt T, Chopin DK, Katz AE
Herbal
therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients
with prostate cancer
J
Urol 2000 Oct;164(4):1229-34 (Clinical Study, Abstract)
|
|
[32]
N.A.
|
|
[33] Not
Found
|
|
[34]
Buckner
JC, Malkin MG, Reed E, Cascino TL, Reid
JM, Ames MM, Tong WP, Lim S, Figg WD
Phase II study of antineoplastons A10 (NSC 648539)
and AS2-1 (NSC 620261) in patients with recurrent glioma
Mayo
Clin Proc 1999 Feb;74(2):137-45 (Clinical Study, Abstract)
|
|
[35] Not
Found
|
|
[36] N.A.
|
|
|
| Chapter 13 - The Value of
Supplements |
[1], [2]
N.A. |
|
[3] Cameron E, Pauling L
Supplemental
ascorbate in the supportive treatment of cancer: Prolongation of survival times
in terminal human cancer
Proc Natl
Acad Sci U S A 1976 Oct;73(10):3685-9 (Clinical Study, Abstract)
|
|
[4] Cameron E, Pauling L
Supplemental
ascorbate in the supportive treatment of cancer: reevaluation of prolongation of
survival times in terminal human cancer
Proc Natl
Acad Sci U S A 1978 Sep;75(9):4538-42 (Clinical Study, Reference)
|
|
[5] Creagan
ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S
Failure
of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced
cancer. A controlled trial
N
Engl J Med 1979 Sep 27;301(13):687-90 (Clinical Study, Abstract)
|
|
[6] Not Found
|
|
[7],
[8] N.A.
|
|
[9] Not Found
|
|
[10] Prasad KN, Cole WC, Kumar B, Prasad KC
Scientific
rationale for using high-dose multiple micronutrients as an adjunct to standard
and experimental cancer therapies
J Am
Coll Nutr 2001 Oct;20(5 Suppl):450S-463S (Review
Article, Abstract |
Full Text)
|
|
[11] Prasad
KN, Kumar A, Kochupillai V, Cole WC
High
doses of multiple antioxidant vitamins: essential ingredients in improving the
efficacy of standard cancer therapy
J Am
Coll Nutr 1999 Feb;18(1):13-25 (Review
Article, Abstract
| Full Text)
|
|
[12] Salganik
RI
The
benefits and hazards of antioxidants: controlling apoptosis and other protective
mechanisms in cancer patients and the human population
J Am
Coll Nutr 2001 Oct;20(5 Suppl):464S-472SReview
Article, Abstract |
Full Text)
|
|
[13] Salganik RI, Albright CD, Rodgers J, Kim J, Zeisel SH,
Sivashinskiy MS, Van Dyke TA
Dietary antioxidant depletion: enhancement of tumor
apoptosis and inhibition of brain tumor growth in transgenic mice
Carcinogenesis
2000 May;21(5):909-14 (Cell Culture Study, Abstract | Full Text)
|
|
[14] Sun AS, Ostadal O, Ryznar V, Dulik I, Dusek J, Vaclavik A, Yeh HC,
Hsu C, Bruckner HW, Fasy TM
Phase I/II
study of stage III and IV non-small cell lung cancer patients taking a specific
dietary supplement
Nutr Cancer 1999;34(1):62-9 (Clinical Study, Abstract)
|
|
[15] Sun
AS, Yeh HC, Wang LH, Huang YP, Maeda H, Pivazyan A, Hsu C, Lewis ER,
Bruckner HW, Fasy TM
Pilot study
of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV
non-small cell lung cancer patients
Nutr
Cancer 2001;39(1):85-95 (Animal Study | Clinical Study,
Abstract)
|
|
[16] Kucuk
O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M,
Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr
Phase II
randomized clinical trial of lycopene supplementation before radical
prostatectomy
Cancer
Epidemiol Biomarkers Prev 2001 Aug;10(8):861-8
(Clinical Study,
Abstract | Full Text)
|
|
[17] N.A.
|
|
[18] Neri B, de Leonardis V, Gemelli MT, di Loro F, Mottola
A, Ponchietti R, Raugei A, Cini G
Melatonin
as biological response modifier in cancer patients
Anticancer Res 1998 Mar-Apr;18(2B):1329-32 (Clinical Study, Abstract)
|
|
[19] Lissoni P, Meregalli S, Nosetto
L, Barni S, Tancini G, Fossati V, Maestroni G.
Increased survival time
in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus
melatonin compared to radiotherapy alone
Oncology
1996 Jan-Feb;53(1):43-6 (Clinical Study, Abstract)
|
|
[20] Lissoni P, Barni S, Ardizzoia A, Paolorossi F, Crispino
S, Tancini G, Tisi E, Archili C, De Toma D, Pipino G, et al
Randomized study with the pineal hormone melatonin
versus supportive care alone in advanced nonsmall cell lung cancer resistant to
a first-line chemotherapy containing cisplatin
Oncology 1992;49(5):336-9 (Clinical Study, Abstract)
|
|
[21] Lissoni P, Brivio O, Brivio F, Barni S, Tancini G,
Crippa D, Meregalli S
Adjuvant
therapy with the pineal hormone melatonin in patients with lymph node relapse
due to malignant melanoma
J Pineal
Res 1996 Nov;21(4):239-42 (Clinical Study, Abstract)
|
|
[22] Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Meregalli
S, Fossati V, Fumagalli L, Brivio F, Tancini G
A
randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus
supportive care alone in metastatic colorectal cancer patients progressing under
5-fluorouracil and folates
Oncology
1995 May-Jun;52(3):243-5
(Clinical Study, Abstract)
|
|
[23] Lissoni P, Paolorossi F, Ardizzoia A, Barni S, Chilelli
M, Mancuso M, Tancini G, Conti A, Maestroni GJ
A
randomized study of chemotherapy with cisplatin plus etoposide versus
chemoendocrine therapy with cisplatin, etoposide and the pineal hormone
melatonin as a first-line treatment of advanced non-small cell lung cancer
patients in a poor clinical state
J Pineal
Res 1997 Aug;23(1):15-9 (Clinical Study, Abstract)
|
|
[24] N.A.
|
|
[25] Tsukagoshi S, Hashimoto Y, Fujii G,
Kobayashi H, Nomoto K, Orita K
Krestin
(PSK)
Cancer Treat Rev
1984 Jun;11(2):131-55 (Clinical Study | Review Article, Abstract)
|
|
[26] Kobayashi
H, Matsunaga K, Oguchi Y
Antimetastatic
effects of PSK (Krestin), a protein-bound polysaccharide obtained from
basidiomycetes: an overview
Cancer
Epidemiol Biomarkers Prev 1995 Apr-May;4(3):275-81 (Review
Article, Abstract)
|
|
[27] Chihara
G
Recent
progress in immunopharmacology and therapeutic effects of polysaccharides
Dev
Biol Stand 1992;77:191-7 (Clinical
Study | Review Article, Abstract)
|
|
[28] Hayakawa
K, Mitsuhashi N, Saito Y, Takahashi M, Katano S, Shiojima K, Furuta M, Niibe
H
Effect
of krestin (PSK) as adjuvant treatment on the prognosis after radical
radiotherapy in patients with non-small cell lung cancer
Anticancer
Res 1993 Sep-Oct;13(5C):1815-20 (Clinical Study, Abstract)
|
|
[29] Kaneko
S, Abe H, Aida T, Tokuda K, Tsuru M, Kitaoka K, Sato M, Iwakuma T, Ueno K,
Kashiwaba T
Evaluation of radiation immunochemotherapy in the
treatment of malignant glioma. Combined use of ACNU, VCR and PS-K
Hokkaido Igaku Zasshi 1983 Nov;58(6):622-30 (Clinical Study,
Abstract)
|
|
[30] N.A.
|
|
[31] Nanba
H, Kubo K
Effect
of Maitake D-fraction on cancer prevention
Ann N Y Acad Sci 1997 Dec 29;833:204-7 (Animal Study,
Reference)
|
|
[32] Arber N,
DuBois RN
Nonsteroidal
anti-inflammatory drugs and prevention of colorectal cancer
Curr Gastroenterol Rep 1999 Oct;1(5):441-8 (Review Article,
Abstract)
|
|
[33] Zurier
RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM,
Laposata M
gamma-Linolenic
acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial
Arthritis
Rheum 1996 Nov;39(11):1808-17 (Clinical Study, Abstract)
|
|
[34] Jiang WG, Bryce RP, Horrobin DF
Essential
fatty acids: molecular and cellular basis of their anti-cancer action and
clinical implications
Crit
Rev Oncol Hematol 1998 Apr;27(3):179-209 (Review Article,
Reference)
|
|
[35] N.A.
|
|
[36] Kenny
FS, Pinder SE, Ellis IO, Gee JM, Nicholson RI, Bryce RP, Robertson JF
Gamma linolenic
acid with tamoxifen as primary therapy in breast cancer
Int J Cancer 2000 Mar 1;85(5):643-8 (Clinical Study,
Abstract)
|
|
[37] Fearon
KC, Falconer JS, Ross JA, Carter DC, Hunter JO, Reynolds PD, Tuffnell Q
An
open-label phase I/II dose escalation study of the treatment of pancreatic
cancer using lithium gammalinolenate
Anticancer Res 1996 Mar-Apr;16(2):867-74 (Clinical Study, Abstract)
|
|
[38] Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC,
Kalfarentzos F
Dietary
omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and
prolong survival for severely ill patients with generalized malignancy: a
randomized control trial
Cancer
1998 Jan 15;82(2):395-402 (Clinical Study, Abstract)
|
|
[39] Ip
C
Review of
the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids,
and conjugated linoleic acid on mammary carcinogenesis in animals
Am J
Clin Nutr 1997 Dec;66(6 Suppl):1523S-1529S
(Animal Study, Abstract)
|
|
[40] Not Found
|
|
[41] Penar
PL, Khoshyomn S, Bhushan A, Tritton TR
Inhibition
of epidermal growth factor receptor-associated tyrosine kinase blocks
glioblastoma invasion of the brain
Neurosurgery
1997 Jan;40(1):141-51 (Cell Culture Study, Abstract)
|
|
[42] Li
D, Yee JA, McGuire MH, Murphy PA, Yan L
Soybean
isoflavones reduce experimental metastasis in mice
J Nutr 1999
May;129(5):1075-8 (Animal Study, Abstract
| Full Text)
|
|
[43] Baltuch
GH, Yong VW
Signal
transduction for proliferation of glioma cells in vitro occurs predominantly
through a protein kinase C-mediated pathway
Brain Res 1996 Feb 26;710(1-2):143-9
(Cell Culture Study, Abstract)
|
|
[44] Zhou
JR, Gugger ET,
Tanaka T, Guo Y, Blackburn GL, Clinton SK
Soybean
phytochemicals inhibit the growth of transplantable human prostate carcinoma and
tumor angiogenesis in mice
J Nutr 1999 Sep;129(9):1628-35
(Animal Study, Abstract
| Full Text)
|
|
[45] Clark
LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover
RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith
CL, Taylor JR
Effects of selenium supplementation for cancer
prevention in patients with carcinoma of the skin. A randomized controlled
trial. Nutritional Prevention of Cancer Study Group
JAMA
1996 Dec 25;276(24):1957-63 (Clinical Study, Abstract)
|
|
[46] Sundaram
N, Pahwa AK, Ard MD, Lin N, Perkins E, Bowles AP Jr
Selenium
causes growth inhibition and apoptosis in human brain tumor cell lines
J Neurooncol 2000;46(2):125-33
(Cell Culture Study, Abstract)
|
|
[47] Kuroda Y, Hara Y
Antimutagenic
and anticarcinogenic activity of tea polyphenols
Mutat Res
1999 Jan;436(1):69-97 (Review Article, Abstract)
|
|
[48] Vigushin
DM, Poon GK, Boddy A, English J, Halbert GW, Pagonis C, Jarman M, Coombes RC
Phase
I and pharmacokinetic study of D-limonene in patients with advanced cancer.
Cancer Research Campaign Phase I/II Clinical Trials Committee
Cancer
Chemother Pharmacol 1998;42(2):111-7 (Clinical Study, Abstract)
|
|
[49] Shen F,
Weber G
Synergistic
action of quercetin and genistein in human ovarian carcinoma cells
Oncol Res 1997;9(11-12):597-602 (Cell Culture Study,
Abstract)
|
|
[50] Kennedy
RS, Konok GP, Bounous G, Baruchel S, Lee TD
The use of a
whey protein concentrate in the treatment of patients with metastatic carcinoma:
a phase I-II clinical study
Anticancer
Res 1995 Nov-Dec;15(6B):2643-9 (Clinical Study, Abstract)
|
|
[51] Verhoeven DT,
Verhagen H, Goldbohm RA, van den Brandt PA, van Poppel G
A
review of mechanisms underlying anticarcinogenicity by brassica vegetables
Chem Biol Interact 1997 Feb 28;103(2):79-129 (Review Article,
Abstract)
|
|
[52] Fahey JW, Zhang Y, Talalay P
Broccoli
sprouts: an exceptionally rich source of inducers of enzymes that protect
against chemical carcinogens
Proc
Natl Acad Sci U S A 1997 Sep 16;94(19):10367-72 (Animal Study,
Abstract | Full Text)
|
|
|
| Chapter 14 - The
Cutting Edge of Cancer Treatment |
[1]
Smith
TJ, Hillner BE, Desch CE
Efficacy and cost-effectiveness of cancer treatment:
rational allocation of resources based on decision analysis
J Natl Cancer Inst 1993
Sep 15;85(18):1460-74 (Review Article, Reference)
|
|
[2]
HA
Fine, JS Loeffler, A Kyritsis, P Wen, PM Black, VA Levin, S Graham, WKA Yung
A phase II trial of the
anti-angiogenic agent,
thalidomide, in patients with recurrent high-grade gliomas
ASCO
Proceedings, 1997 Annual Meeting, Abstract No. 1372 (Clinical Study)
|
|
[3] Jo
Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of Carboplatin and Thalidomide in
Recurrent Glioblastoma Multiforme
ASCO
Proceedings, 1999 Annual Meeting, Abstract No.
551 (Clinical Study)
|
|
[4] N.A.
|
|
[5]
Boehm
T, Folkman J, Browder T, O'Reilly MS
Antiangiogenic
therapy of experimental cancer does not induce acquired drug resistance
Nature 1997 Nov 27;390(6658):404-7 (Animal Study, Abstract)
|
|
[6]
Yokoyama
Y, Dhanabal M, Griffioen AW, Sukhatme VP, Ramakrishnan S
Synergy
between angiostatin and endostatin: inhibition of ovarian cancer growth
Cancer Res 2000 Apr 15;60(8):2190-6 (Animal Study, Abstract
| Full Text)
|
|
[7]
Gagliardi AR, Hennig B, Collins DC
Antiestrogens inhibit endothelial cell growth
stimulated by angiogenic growth factors
Anticancer Res 1996 May-Jun;16(3A):1101-6 (Cell Culture Study, Abstract)
|
|
[8]
Cai
J, Jiang WG, Mansel RE
Inhibition
of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid
Prostaglandins
Leukot Essent Fatty Acids 1999 Jan;60(1):21-9
(Cell Culture Study, Abstract)
|
|
[9] Zhou
JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK
Soybean
phytochemicals inhibit the growth of transplantable human prostate carcinoma and
tumor angiogenesis in mice
J Nutr 1999
Sep;129(9):1628-35 (Animal Study, Abstract)
|
|
[10]
Yihai
Cao and Renhai Cao
Angiogenesis inhibited by drinking tea
Nature 1999 Apr 1;398(6726):381 (Letter, Reference
| Full Text)
|
|
[11]
Arbiser
JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR
Curcumin is an
in vivo inhibitor of angiogenesis
Mol
Med 1998 Jun;4(6):376-83 (Cell
Culture Study | Animal Study, Abstract)
|
|
[12]
Majewski
S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S
Vitamin D3 is a potent inhibitor of tumor
cell-induced angiogenesis
J Investig
Dermatol Symp Proc 1996 Apr;1(1):97-101 (Animal Study, Abstract)
|
|
[13]
Jiang
C, Agarwal R, Lu J
Anti-angiogenic
potential of a cancer chemopreventive flavonoid antioxidant, silymarin:
inhibition of key attributes of vascular endothelial cells and angiogenic
cytokine secretion by cancer epithelial cells
Biochem Biophys Res Commun 2000 Sep 16;276(1):371-8
(Cell Culture Study, Abstract)
|
|
[14]
Verheul
HM, Panigrahy D, Yuan J, D'Amato RJ
Combination
oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth
in rabbits
Br J
Cancer 1999 Jan;79(1):114-8 (Animal Study, Abstract)
|
|
[15]
Gorski
DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP,
Soff GA, Kufe DW, Weichselbaum RR
Potentiation of the antitumor effect of ionizing
radiation by brief concomitant exposures to angiostatin
Cancer Res 1998 Dec 15;58(24):5686-9 (Animal Study, Abstract)
|
|
[16]
Li D, Williams
JI, Pietras RJ
Squalamine
and cisplatin block angiogenesis and growth of human ovarian cancer cells with
or without HER-2 gene overexpression
Oncogene 2002 Apr 25;21(18):2805-14
(Cell Culture Study | Animal Study, Abstract)
|
|
[17],
[18] N.A.
|
|
[19] Snelling
L, Miyamoto CT, Bender H, Brady LW, Steplewski Z, Class R, Emrich J, Rackover MA
Epidermal
growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in
the adjuvant treatment of high-grade astrocytomas
Hybridoma
1995 Apr;14(2):111-4 (Clinical Study, Abstract)
|
|
[20],
[21], [22] N.A.
|
|
[23]
Pietro Riva, Giancarlo
Franceschi, Massimo Frattarelli, Nada Riva,
Graziano Guiducci, Anna Maria Cremonini, Graziano Giuliani, Michela Casi,
Rossella Gentile, Annti A. Jekunen, Kalevi J. A. Kairemo
131I
Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade
Malignant Glioma: Phase I and II Study
Acta Oncologica, Volume 38, Number 3/May 18, 1999, 351 - 359
(Clinical Study,
Abstract)
|
|
[24] N.A.
|
|
[25]
Baselga
J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT,
Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L
Phase II study
of weekly intravenous trastuzumab (Herceptin) in patients with
HER2/neu-overexpressing metastatic breast cancer
Semin
Oncol 1999 Aug;26(4 Suppl 12):78-83
(Clinical Study,
Abstract)
</ | |
